Olink Acquires IP from In Situ RCP | GenomeWeb

NEW YORK (GenomeWeb News) – Olink Bioscience said today that it has acquired a family of patents from the Danish firm In Situ RCP that it plans to use in its nucleic acid amplification and protein analysis applications.

The Uppsala, Sweden-based company said the three patents are related to target primed rolling circle amplification and amplifying circular molecules.

Olink's product line is based on its proximity ligation assay technology, which uses dual recognition of analytes and a DNA amplification reporter system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.